Literature DB >> 22241003

Surgical strategy for tubercular abscess in the chest wall: experience of 120 cases.

Bo Deng1, Qun-You Tan, Ru-Wen Wang, Yong He, Yao-Guang Jiang, Jing-Hai Zhou, Yong-Gang Liang.   

Abstract

OBJECTIVES: We aim to optimize surgical strategy to decrease relapse of tubercular abscess in the chest wall (TACW).
METHODS: The records of 120 patients who underwent surgical treatment for TACW from May 2005 to March 2011 were retrospectively reviewed. We conducted the following surgical treatment as '6C + A' by abbreviating the first alphabet of each step: (i) careful exploration of the abscess; (ii) complete resection; (iii) cavity washing using sodium bicarbonate solution; (iv) coverage using muscle flap; (v) continuous suction and drainage; (vi) compression dressing and (vii) anti-tuberculosis medication.
RESULTS: One hundred and thirteen cases were discharged for rehabilitation with the first stage wound healing (113/120). Four cases postoperatively suffered from subcutaneous fistula which was healed after dressing changes for 1-2 months. Three patients with an abscess relapse underwent the second operation 2 months after the first operation. Follow-ups ranged from 2 months to 6 years and demonstrated no recurrence.
CONCLUSIONS: We deem the surgical procedures '6C + A' effective to obviate relapse of TACW.

Entities:  

Mesh:

Year:  2012        PMID: 22241003     DOI: 10.1093/ejcts/ezr209

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  A case report of tuberculous abscess of the chest wall accompanied with pulmonary carcinoma.

Authors:  Shungo Yukumi; Motohiro Yamashita; Hiraku Ichiki; Hideaki Suzuki; Kei Ishimaru; Seiya Ueda; Akira Watanabe; Chika Sato; Masahiro Abe
Journal:  Respir Med Case Rep       Date:  2013-09-03

2.  Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery.

Authors:  Y I Han; Qiuyue Zhao; Daping Yu; Zhidong Liu
Journal:  Exp Ther Med       Date:  2015-01-27       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.